Breast cancer, the most frequently diagnosed cancer worldwide (3, 4), is classified into four distinct subtypes based on immunohistochemical (IHC) and genetic profiling of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status. This evidence concerns the gene PGR and breast cancer.